Other News Topics (not Types of Cancer)

CancerConnect On Line Support Community Available for Cancer Patients and Caregivers Impacted by Hurricane Irma (09-8-2017)

CancerConnect is a specialized social network for patients with cancer and their caregivers. All the members of the CancerConnect community are hoping for the best for everyone in Florida facing the coming wrath of Hurricane Irma. We are especially concerned... Continue Reading

Liquid Biopsies Find Distinct Genomic Profiles in Most Patients with Carcinoma of Unknown Primary (09-7-2017)

New research suggests that a simple blood test to evaluate circulating tumor DNA (ctDNA) can correctly identify distinct genomic profiles with potentially treatable targetable alterations in patients with carcinoma of unknown primary (CUP).1 Identifying... Continue Reading

New Study Suggests Most Cancers are Unavoidable Irrespective of Life Style (07-19-2017)

Two thirds of cancers are unavoidable even if you live a healthy life, according to a study published by doctors from John Hopkins.  The research, published in the journal Science, indicates that the majority of cancer-causing mutations are due to DNA... Continue Reading

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed (04-21-2017)

Small, phase one trial of a dendritic cell vaccine supports further study in larger trials A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination... Continue Reading

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer (03-31-2017)

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior... Continue Reading

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers (03-23-2017)

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their name,... Continue Reading

Dealing with Distress (03-17-2017)

Why it’s important to acknowledge distress during cancer care and what to do about it By Teresa L. Deshields and Clorinda Walley The moment a patient is diagnosed with cancer, one symptom is likely to surface: distress. Sadness, fear, helplessness,... Continue Reading

Xermelo-new option for controlling symptoms of Carcinoid Syndrome (03-1-2017)

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is... Continue Reading

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors (02-23-2017)

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and... Continue Reading

It’s in the Genes: Genetic Testing Tutorial (10-7-2016)

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health issues. In this recurring column, experts provide... Continue Reading

Next Page »